Incyte (INCY) Accumulated Expenses (2010 - 2026)

Incyte (INCY) reported Accumulated Expenses of $1.1 billion for Q1 2026, up 962.35% on a YoY basis from $102.8 million in Q1 2025, and up 378.93% quarter-over-quarter from $228.1 million in Q4 2025.

Incyte (INCY) Accumulated Expenses (2010 - 2026) Analysis & Trends

Incyte has reported Accumulated Expenses for 17 years, with the latest figure at $1.1 billion in Q1 2026.

  • For the quarter ending Q1 2026, Accumulated Expenses rose 962.35% year-over-year to $1.1 billion; the trailing twelve-month figure through Mar 2026 stood at $1.1 billion (up 962.35% YoY), and the FY2025 full-year result was $228.1 million, down 81.18% from the prior year.
  • Accumulated Expenses for Q1 2026 stood at $1.1 billion, up from $228.1 million in the prior quarter.
  • The five-year high for Accumulated Expenses was $1.2 billion in Q4 2024, with the low at $37.1 million in Q1 2022.
  • Historically, Accumulated Expenses has averaged $517.7 million across 5 years, with a median of $228.1 million in 2025.
  • Annual changes were most pronounced in 2022 — Accumulated Expenses sank 91.18% — and 2026, when it soared 962.35%.
  • Incyte's Accumulated Expenses stood at $138.8 million in 2022, then surged by 574.23% to $935.6 million in 2023, then increased by 29.55% to $1.2 billion in 2024, then sank by 81.18% to $228.1 million in 2025, then surged by 378.93% to $1.1 billion in 2026.
  • The last three Accumulated Expenses figures came in at $1.1 billion (Q1 2026), $228.1 million (Q4 2025), and $948.4 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Incyte 19.62 Bn 15.60 Bn 1.17 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.09 Bn
Dec 31, 2025 228.07 Mn
Sep 30, 2025 948.44 Mn
Jun 30, 2025 129.11 Mn
Mar 31, 2025 102.82 Mn
Dec 31, 2024 1.21 Bn
Sep 30, 2024 1.13 Bn
Jun 30, 2024 1.03 Bn
Mar 31, 2024 89.11 Mn
Dec 31, 2023 935.57 Mn
Sep 30, 2023 124.78 Mn
Jun 30, 2023 810.85 Mn
Mar 31, 2023 84.72 Mn
Dec 31, 2022 138.76 Mn
Sep 30, 2022 106.31 Mn
Jun 30, 2022 598.81 Mn
Mar 31, 2022 37.13 Mn
Dec 31, 2021 108.96 Mn
Sep 30, 2021 23.89 Mn
Jun 30, 2021 413.07 Mn